Chapter 12: Jonathan - Forced Marriage to the CEO

Jonathan

As I feared, the first text was only a precursor. We had a bit of a reprieve for a several days then the onslaught came in earnest. Since then both Jessica and I have received multiple requests for responses to allegations of misconduct. As per our contract, we cannot publicly speak for Jessica without her prior approval, so we have to shut down any information leaks the best way we can and lend her our PR team as she requests it.

The compliance lockdown starts first thing, today. The security team revokes the keycards at dawn. By ten in the morning, the fourth-floor smells of stale sweat and anxiety. Server towers hum behind locked glass, their blue lights flashing as external access cuts to black.

The whole truth is that someone is building a case against this company. Somehow, they are getting enough insider information to raise enough pertinent questions without having to provide a shred of proof. I intend to understand the shape of this attack before they finish putting it together.

Critical staff are in the war room. It’s the glass conference room on four that nobody calls a war room out loud. The data integrity team is reviewing every adverse event report filed.

I stand at the window in my office and watch Cambridge. The sky is the color of wet asphalt, heavy with December rain that hasn’t started falling yet. I think about the sequence of events. The short interest moved two percent overnight before the reporters ever hit the phone lines. Someone has been building this for months so the accusations that the wedding was the origin is false. It was used as an accelerant.

My phone buzzes on the desk, Harlan’s name appears on the screen.

“Jonathan.” It sounds like Harlan’s patience is stretched slightly thinner than usual. “The board has asked for an emergency call this afternoon.”

“What time?”

“Three.”

“Is this about the press inquiry?” I ask.

“Yes, but that’s only part of it. There are some members who have raised questions about your leadership stability. Given the timing of the marriage and the profile of the family you just joined.”

“Her name is Jessica, and the board approved the candidate list before it has handed to me.”

“I understand that. And I want you to know that I personally backed the choice.” Harlan’s voice shifts into something more clinical. “The concern being raised is the weaponization of the optics, Jonathan. A nonprofit executive with ties to vulnerable patient populations invites exactly the kind of questions we cannot afford right now. They’re looking at the timeline and calling it a desperate distraction.”

The characterization hits me cold. I keep my knuckles loose against the glass to keep me from losing my temper.

“She is not the issue; the short sellers are. Tell Richard I’ll see them at three.”

I end the call before he can offer any more perspective.

* * *

By two in the afternoon, the legal floor is steeped in fear. I stand at the head of the long conference table while the compliance and internal audit teams cycle through.

“Full audit on every vendor tied to the OncoNova program,” I say, my voice level. “Cross-reference with the short interest spikes. I want to know who’s feeding these outlets before the next trading day.”

At three, I move to the empty conference room next door and the screen at the end lights up with twelve small squares. The emergency board session begins without a greeting. Richard doesn’t waste time on formalities; he brings up the short interest report first, that sights another three percent drop. The blade is pressing closer.

Harrington is the first to speak from his square. He’s old money with old grudges. He leans close to his camera, his background showing a library that probably cost more than my first lab. “When we voted to clear Jessica Shaw for the liquidity clause, Jonathan, the consensus was that an unassailable nonprofit director provided pristine public relations. We didn’t anticipate you handing the short sellers a stick to beat us with.”

“My marriage is compliant with the timeline,” I say, keeping my hands flat on the table. “The conditions have been met.”“The conditions were meant to secure the company’s capitalization ahead of AdComm, not raise questions about your fundamental stability.” Richard cuts in, his voice milder but heavier. “We agreed to this match because her clinical background lent credibility to our patient advocacy profile. But the whispers hitting the Globe aren’t praising the charity work. They’re framing this sudden wedding as a chaotic, last-minute maneuver by a CEO who’s losing his grip on the narrative.”

“My marriage is private,” I say. The words come out cold, precise, and absolute. “It has no bearing on our operational focus.”

“Perception doesn’t care about your focus,” Harrington shoots back. “If a reporter prints that the leader of this company is erratic enough to bind himself to Gerald Shaw’s family weeks before a major trial defense, the market reads it as panic. Worse, they’re already asking if her nonprofit’s patient pool is being leveraged for unauthorized trial use to pad our Phase 3 data. You assured us she was a stable asset. Right now, this look of sudden leadership instability is a luxury we cannot afford.”

They see her as a calculated choice that’s backfiring, a risk factor that I underestimated. They don’t see Jessica or the steel in her spine when she talks about her clients. They don’t know when she stayed up until the small hours at the kitchen island, hair pulled into a messy knot, fiercely tearing apart a city budget proposal that cut funding for her families. Or the small things we’ve built together in the last five weeks: the shared silence at dawn, the subtle touches when she’s making a point, or how her eyes catch mine across the table when the careful distance drops. In five weeks, I’ve learned exactly who she is, and I have zero intention of losing her.

“She is my wife,” I say, and the word carries a weight I didn’t expect it to. “The board vetted the candidates and approved the execution. Focus on the short position, I am handling the optics.”

“See that you do,” Richard says. “We backed this arrangement to protect OncoNova, Jonathan. If the appearance of your personal life destroys public confidence in your leadership anyway, the board will take steps to insulate the company, with or without your agreement.”

The call ends with a collective click of twelve windows closing at once.

* * *

The room next door is empty except for Elizabeth. She stays near the door, a stack of data printouts held tightly against her ribs.

I’ve made a decision somewhere between Harrington’s second accusation and Richard’s last threat, and I say it out loud now so it’s real before I can talk myself out of it.

“I want an independent review of the trial data. We need a full third-party audit for enrollment records, informed consent documentation, and adverse event reporting. Someone outside this building, outside our payroll, with no stake in the outcome.”

Elizabeth goes very still. “You want to hand an outside firm access to everything?”

“I want to hand an outside firm access to everything before someone forces us to. If the data’s clean—and it is—an independent set of eyes saying so publicly is worth more than anything our own compliance team can produce. Nobody trusts a man grading his own exam.”

“The board didn’t ask for this.”

“The board asked me to fix the optics, and this fixes the optics.” I meet her eyes. “It also happens to be the right thing to do, which is not usually how these decisions work out, so I’d like to enjoy it for a minute.”

She’s already writing before I finish the sentence, and for the first time all day something in my chest loosens by half a degree.

“You’re keeping her out of the loop,” she says, not looking up from her notes. It isn’t a question.

“She doesn’t need this on her plate.” The excuse is defensible, but it drops like lead between us.

“She’s lived with you for five weeks, Jonathan. She isn’t an asset you can park in a vault. If she finds out about the market volatility through a press notification instead of you, you won’t just lose her cooperation, you’ll lose her trust.”

“I’m protecting her.”

“From the wolves, or from yourself?”

I don’t answer, because the truth isn’t as simple as Elizabeth wants it to be. If I let Jessica see how fast this is unraveling, she might pull away. Or worse, she might try to step into the line of fire to protect Anchor Point. I won’t let her become collateral damage because of the board’s sudden loss of nerve. “I’ve told our communications team to keep the marriage out of the corporate statements. Strategic arrangement only, No details.”

“You’re playing a dangerous game,” is the pushback I get.

* * *

The rest of the afternoon is a grind of legal definitions and scenario planning. I sign off on enhanced crisis protocols, review draft responses to the Globe, and sit through another rehearsal where my answers about trial enrollment come out colder and more mechanical than before.

My mind drifts to the penthouse and how I wish I were there now with Jessica. I find that I appreciate the simple cues of her presence like her heavy dark coat hanging right beside mine in the entryway. I have to pull it back. She’s safer if she stays invisible.

By night, the building is mostly empty. The glowing blue sign of OncoNova reflects off the dark river below. My shoulders ache and my jaw is tight. I tell myself it’s just the long day, just the pressure of the upcoming committee hearing. Not the way she’s begun to occupy more space in my head since the wedding.

I pack my bag and take the private elevator down to the garage where my driver waits. We’re halfway across the bridge when my phone begins to light up. There are multiple alerts and social media tags from Bloomberg and Business Wire.

The story didn’t wait for the morning edition. It dropped just shy of midnight.

The headline slams into me. Whistleblower Alleges Data Integrity Issues at OncoNova Biotechnologies: Safety of Flagship Gene Therapy Questioned

I scroll down, the text blurring slightly before my eyes focus on the details. Anonymous quotes from “close associates of the board.” Carefully worded implications about personal entanglements affecting executive focus and corporate stability. Then the knife goes in deeper.

Questions have arisen regarding the sudden timeline of the marriage, which unites OncoNova’s leadership with Jessica Shaw, Executive Director of Anchor Point, a prominent Boston nonprofit specializing in cognitive care and patient advocacy. Sources close to the situation suggest regulatory investigators may look into whether the unorthodox timing points to erratic executive leadership, or if these personal ties create conflicts of interest regarding unauthorized patient use for OncoNova’s pending Phase 3 data.

They didn’t just target me or question my stability. They targeted her house. They took her life’s work, the place she spent eight years building, and turned it into a weapon against my corporate standing.

They took five weeks of quiet, careful navigation and turned it into a public spectacle. They didn’t care about the night five days ago when she came home soaked from the cold rain and we sat on the floor against the low sofa with our shoulders touching, eating takeout in a silence that felt easy. Or that we’ve spent this time meticulously respecting each other’s boundaries while simultaneously wearing them down.

This isn’t just a short seller trying to squeeze a few million dollars out of a stock drop. This is precision sabotage timed to hit right before the AdComm panel opens.

The first thought that cuts through the anger isn’t about OncoNova’s stock price or the legal defenses we spent twelve hours preparing.

It’s about Jessica opening her phone in that quiet penthouse, reading these words, and realizing exactly how much danger my world has brought to her door.